Literature DB >> 395644

The role of hepatic control of glucose homeostasis in the etiology of neonatal hypo- and hyperglycemia.

R M Cowett, R Schwartz.   

Abstract

Precise control of glucose homeostasis is well recognized in the adult. Going from a period of complete dependence on the maternal organism for delivery of substrate, the fetus is born not only with a need to furnish himself with glucose for energy and rapid growth but also with the need to maintain a balance between glucose deficiency and excess. This is especially difficult because of the intermittent nature of exogenous oral intake in the neonatal period. Development of glucose homeostasis requires a balance between substrate availability (both absolute and relative) and coordination of hormonal, neural and enzymatic systems. The large number of conditions producing or associated with both hypo- and hyperglycemia in the newborn, especially the low birth weight or sick neonate, emphasizes this vulnerability. Newer techniques including stable isotope methodology, now being employed with increasing frequency, will help define maturation of neonatal carbohydrate homeostasis and further clarify nutritional requirements in this transitional period.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 395644

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  3 in total

Review 1.  Prevention and management of neonatal hypoglycaemia.

Authors:  J M Hawdon; M P Ward Platt; A Aynsley-Green
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747

2.  The role of pancreatic insulin secretion in neonatal glucoregulation. II. Infants with disordered blood glucose homoeostasis.

Authors:  J M Hawdon; A Aynsley-Green; K Bartlett; M P Ward Platt
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

3.  Risks and benefits of prophylactic cyclic parenteral nutrition in surgical neonates.

Authors:  T Hang Nghiem-Rao; Laura D Cassidy; Elizabeth M Polzin; Casey M Calkins; Marjorie J Arca; Praveen S Goday
Journal:  Nutr Clin Pract       Date:  2013-10-09       Impact factor: 3.080

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.